Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HLCS | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | CHST1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | UNC13B | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
mRNA | ZNF223 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
mRNA | ZNF701 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
mRNA | MAP3K2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | RP11-463C8.4 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | SDAD1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
mRNA | DNAJC16 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
mRNA | FIG4 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |